HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Evaluation of the Preventing AIDS Through Live Movement and Sound (PALMS) Intervention for Minority Adolescents [Phase 1, Phase 2]
This update reports on the completion status of the PALMS behavioral intervention trial for minority adolescents at risk for HIV infection.
-
CLINICAL_TRIALS trial_result · 2010-01-06Clinical Trial Update: Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection. [Phase 2]
A Phase 2 safety and efficacy study of MPC-4326 for HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India [Phase 1]
Phase 1 safety and acceptability study of PRO 2000 vaginal gel in HIV-uninfected women in India has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2) [Phase 3]
RESIST-2 is a Phase 3 trial comparing tipranavir/ritonavir to a genotypically defined protease inhibitor/ritonavir in HIV-infected patients;…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: TOTEM: Switch From Other Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to Once Daily Truvada [Phase 4]
Phase 4 TOTEM trial reports switching from other NRTIs to once-daily Truvada in HIV infection; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation [Phase 3]
Phase 3 trial evaluating the safety and antiviral activity of tipranavir (TPV) in HIV-infected patients coinfected with hepatitis C and/or h…
-
CLINICAL_TRIALS trial_result · 2009-12-21Clinical Trial Update: Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function [Phase 4]
Phase 4 pharmacokinetics and safety study of maraviroc in HIV-infected individuals with varying degrees of renal impairment and normal renal…
-
CLINICAL_TRIALS research · 2009-12-21Clinical Trial Update: Exercise for Patients With HIV Infections [Phase 2, Phase 3]
Clinical trial update on Phase 2 and Phase 3 studies evaluating exercise for people with HIV infection and associated lipodystrophy. The cur…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
A completed study comparing neuropsychiatric outcomes in HIV-positive and HIV-negative individuals who use drugs.
-
CLINICAL_TRIALS research · 2009-12-09Clinical Trial Update: Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels [NA]
Completed clinical trial evaluating rosiglitazone (Avandia) on vascular outcomes in individuals with HIV infection and atherosclerosis.
-
CLINICAL_TRIALS trial_result · 2009-12-02Clinical Trial Update: Efficacy Study of T Cell Vaccination in HIV Infection [Phase 2]
Phase 2 efficacy study evaluating a T Cell Vaccination for HIV infection has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-01Clinical Trial Update: MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED) [Phase 3]
A Phase 3 trial of maraviroc (MK0518) in HIV-infected patients switched from a protease inhibitor regimen was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC [Phase 3]
Phase 3 randomized trial in HIV infection comparing tipRanavir/r with therapeutic drug monitoring (TDM) versus standard of care was terminat…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)
This clinical trial update reports results from the SMART study, comparing structured treatment interruptions to continuous antiretroviral t…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route [Phase 1]
Phase 1 safety study comparing transcutaneous versus intramuscular administration of a vaccine. Participants include healthy volunteers and …
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients [Phase 2]
This Phase 2 study evaluated two immunization schedules of the ALVAC-HIV vCP1452 vaccine in chronically HIV-infected patients, focusing on i…
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) [Phase 4]
A Phase 4 study evaluating chemotherapy plus rituximab and highly active antiretroviral therapy for patients with diffuse large B-cell lymph…
-
FDA approval · 2009-11-24FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
The FDA approved a supplemental application for etravirine (ETRAVIRINE) submitted by Patriot Pharmaceuticals. This action updates labeling t…
-
CLINICAL_TRIALS trial_result · 2009-11-23Clinical Trial Update: Pilot Trial of a Synbiotic in HIV+ Patients [NA]
A completed pilot trial evaluating a synbiotic in HIV-infected patients.
-
FDA approval · 2009-11-20FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Selzentry (maraviroc) from ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2009-11-20Clinical Trial Update: Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients [Phase 4]
Phase 4 trial evaluating safety and immune response to an adjuvanted A(H1N1) influenza vaccine in HIV-infected and immunosuppressed adults.
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) [Phase 3]
Phase 3 randomized trial evaluating tipranavir in multidrug-resistant HIV infection; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED) [Phase 3]
A Phase 3 trial of maraviroc (MK0518) in HIV-infected patients switched from a protease inhibitor regimen was terminated.
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125 [Phase 3]
A Phase 3 pilot trial evaluated switching HIV patients with central nervous system toxicity from efavirenz to etravirine (TMC125) to assess …
-
CLINICAL_TRIALS trial_result · 2009-11-18Clinical Trial Update: Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects [Phase 1]
Phase 1 pharmacokinetic study evaluating abacavir when co-administered with boosted darunavir/ritonavir or with raltegravir in HIV-infected …